replacing mercuty fillings improved health; research

[Guest guest]

Subject: [mnkids] Medical Case Reports__ 71% of patients with MS, autoimmune

thyroiditis improve with replacements of mercury in amalgam fillings.

> MN Kids Enviro Health <mnkids@...> -- posted by

> dwallinga@...

> ============================================================

>

> Mercury & autoimmune conditions/MS

>

> Prochazkova J, Sterzl I, Kucerova H, Bartova J, Stejskal VD; The

> beneficial effect of amalgam replacement on health in patients with

> autoimmunity. Neuro Endocrinol Lett. 2004 Jun;25(3):211-8.

>

> http://www.nel.edu/pdf_/25_3/NEL250304A07_Prochazkova_.pdf

>

> BACKGROUND: Patients with certain autoimmune and allergic diseases, such

> as systemic lupus, multiple sclerosis, autoimmune thyroiditis or atopic

> eczema, often show increased lymphocyte stimulation by low doses of

> inorganic mercury in vitro. The patients often report clinical metal

> hypersensitivity, especially to nickel.

>

> OBJECTIVE AND METHODS: In this study we examined the health impact of

> amalgam replacement in mercury-allergic patients with autoimmunity. The

> suitability of MELISA®, an optimized lymphocyte stimulation test, for

> the selection of susceptible patients and monitoring of sensitization

> was also examined. Amalgam fillings were replaced with composites and

> ceramic materials. Follow-up health status and lymphocyte reactivity

> were assessed and evaluated half a year or later following amalgam

> removal.

>

> RESULTS: Results of lymphocyte reactivity measured with MELISA®

> indicate that in vitro reactivity after the replacement of dental

> amalgam decreased significantly to inorganic mercury, silver, organic

> mercury and lead. Out of 35 patients, 25 patients (71%) showed

> improvement of health. The remaining patients exhibited either unchanged

> health (6 patients, 17%) or worsening of symptoms (4 patients, 11%). The

> highest rate of improvement was observed in patients with multiple

> sclerosis, the lowest rate was noted in patients with eczema. The

> initial mercury-specific lymphocyte reactivity was significantly higher

> in the responder group, than in the non-responders, whose health was not

> improved by amalgam removal. All patients with health improvement after

> amalgam replacement showed reduced proliferation to inorganic mercury in

> follow-up MELISA®. In vitro responses to phenylmercury and nickel did

> not differ between the groups.

>

> CONCLUSIONS: Mercury-containing amalgam may be an important risk factor

> for patients with autoimmune diseases. MELISA® is a valuable tool for

> selection of patients for amalgam replacement and also for monitoring of

> metal allergies.

>

> Wallinga, MD, MPA

> Director, Food and Health Program

> Institute for Agriculture and Trade Policy

> 2105 First Avenue South

> Minneapolis, MN 55404

> dwallinga@...

> 612-870-3418

> www.iatp.org/foodandhealth

>

============================================================

> View the ARCHIVES of this list at:

> http://lists.iatp.org/listarchive/

>

> For help with listserv SUBSCRIPTIONS visit:

> http://lists.iatp.org/listarchive/subscriptions.cfm

>